Propel Bio Management »

Marinus Pharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Marinus Pharmaceuticals (MRNS) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Marinus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Marinus Pharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marinus Pharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 180k 10.87

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Marinus Pharmaceuticals

Eventide Asset Management
Franklin Resources
Cormorant Asset Management
venBio Select Advisor
Jennison Associates
Vanguard Group
Lion Point Capital
Bleichroeder
GMT Capital Corp
Ikarian Capital
Citadel Advisors
Opaleye Management
Standard Life Aberdeen
Point72 Asset Management
Superstring Capital Management

View all funds holding Marinus Pharmaceuticals